Daiichi Sankyo’s European division is teaming up with German medtech Gaia to sell the latter...
Daiichi
Four years after he resigned as chief medical officer at Novartis in the wake of...
Daiichi Sankyo’s development of antibody-drug conjugates continues to hit turbulence. Despite the success of Enhertu,...
Daiichi Sankyo and Merck & Co. have reported midphase ovarian cancer data, clearing the partners to...